Advertisement

Meyka AI - Contribute to AI-powered stock and crypto research platform
Meyka Stock Market API - Real-time financial data and AI insights for developers
Advertise on Meyka - Reach investors and traders across 10 global markets
Loading...

Drugs Made In America Acquisition Corp. Units

DMAAU•NASDAQ
Financial Services
Financial - Conglomerates
$10.50
$-0.05(-0.47%)
U.S. Market opens in 8h 10m

Drugs Made In America Acquisition Corp. Units (DMAAU) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Drugs Made In America Acquisition Corp. Units (NASDAQ:DMAAU).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

DMAAU Technical Analysis Summary

Drugs Made In America Acquisition Corp. Units stock currently shows a bullish trend, supported by momentum and strong buying pressure.

Overall Sentiment:Buy
Momentum:Neutral to Bullish (RSI: 53.40)
Trend Strength:Very Strong (ADX: 62.40)
Volatility:Medium (ATR: 0.51)
Support/Resistance:$10.51 – $10.58 (Bollinger Bands)

This mix signals that Drugs Made In America Acquisition Corp. Units is trading with strong momentum and healthy trend support.

Momentum Indicators

RSI (14): 53.40

Bullish
Above midpoint suggests upward bias.

Stochastic %K: 99.58

Bearish
Overbought levels may trigger pullback.

Williams %R: -0.47

Bearish
Overbought levels may trigger correction.

Rate of Change (ROC): 0.00

Neutral
Price change is minimal.

Takeaway:Drugs Made In America Acquisition Corp. Units shows steady upward momentum, supported by improving signals.

Trend & Volatility

MACD: 0.01

Bullish
Bullish, trend momentum is strengthening.

ADX: 62.40

Very Strong
Very strong trend, powerful directional momentum.

ATR (14): 0.51

Low
Low volatility, stable price action.

CCI (14): 33.81

Bullish
Bullish, momentum building upward.

Takeaway:Drugs Made In America Acquisition Corp. Units shows a firm trend supported by momentum, though one signal suggests caution.

Support & Resistance indicators
Bollinger Bands
Upper Band
$10.58
Middle Band (SMA 20)
$10.55
Lower Band
$10.51
Current Position
Below Lower Band

Takeaway:Drugs Made In America Acquisition Corp. Units trades near the lower band, signaling oversold conditions and potential rebound.

Keltner Channels
Upper Channel
$11.56
Middle Line (EMA 20)
$10.54
Lower Channel
$9.53
Squeeze Status
Squeeze On

Takeaway:Drugs Made In America Acquisition Corp. Units trades around the middle line, reflecting balanced price action.

Volume & Money Flow Analysis
On-Balance Volume-64.47K
Money Flow Index64.73Bullish, inflows support continued momentum.
Relative Vigor Index33.61Bearish, price momentum favors sellers.

Overall Takeaway:DMAAU shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Drugs Made In America Acquisition Corp. Units, here are the key trading signals and recommendations:

Bullish Signals

RSI above 50 → positive momentum from buyers.

MACD above 0 → bullish trend confirmation.

ADX above 20 → strong underlying trend.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Drugs Made In America Acquisition Corp. Units are mixed, suggesting a Hold or wait-and-see approach.

Technical Analysis FAQ